C–C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation
Open Access
- 1 March 2016
- journal article
- research article
- Published by Taylor & Francis in Hematology
- Vol. 21 (6) , 343-350
Abstract
Background: Vitamin D (VD) deficiency results in a worse prognosis in patients with chronic lymphocytic leukemia (CLL) and may affect the production of cytokines. Nonetheless, there is the lack of studies dealing with VD supplementation and its impact on chemokines in CLL patients. Aim: The primary endpoint of our interventional study was to evaluate the effect of cholecalciferol supplementation on serum chemokines levels in CLL patients. Materials and methods: Eighteen subjects with CLL were enrolled for the study. Six-month-long cholecalciferol supplementation was performed in CLL patients with serum 25-OH-D3 levels below 30 ng/ml. Cytokines levels were assessed at the beginning of the study and after 6 months. Baseline measurements of cytokines were compared to those in apparently healthy controls. Results: Increased levels of CCL2, CCL3, CCL4, CXCL8, CXCL10, TNFα, bFGF, G-CSF, and VEGF were found in CLL patients in comparison with the healthy controls. In the course of the VD supplementation a decrease in serum levels of chemokines CCL11, CCL3, and cytokine PDGF-BB was observed. The decrease of CCL11 was found in CLL patients on VD supplementation solely, whereas the decrease of CCL3 and PDGF-BB was observed in CLL subjects on both chemotherapy and VD supplementation. Conclusion: The VD supplementation may exert beneficial effect on chemokines levels in CLL patients with VD deficiency.Keywords
Funding Information
- Medical University of Silesia in Katowice (KNW-2-044/D/4/N)
This publication has 52 references indexed in Scilit:
- Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaBlood, 2011
- Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunityJournal of Bone and Mineral Research, 2011
- CCL11–CCR3 Interactions Promote Survival of Anaplastic Large Cell Lymphoma Cells via ERK1/2 ActivationCancer Research, 2011
- CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemiaBlood, 2011
- Platelet-derived growth factor (PDGF)–PDGF receptor interaction activates bone marrow–derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switchBlood, 2010
- Vitamin D Insufficiency and Prognosis in Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2010
- Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunityJournal of Molecular Medicine, 2010
- Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cellsBritish Journal of Pharmacology, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicatorsLeukemia & Lymphoma, 2008